Literature DB >> 21289626

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.

Ryan Lister1, Mattia Pelizzola, Yasuyuki S Kida, R David Hawkins, Joseph R Nery, Gary Hon, Jessica Antosiewicz-Bourget, Ronan O'Malley, Rosa Castanon, Sarit Klugman, Michael Downes, Ruth Yu, Ron Stewart, Bing Ren, James A Thomson, Ronald M Evans, Joseph R Ecker.   

Abstract

Induced pluripotent stem cells (iPSCs) offer immense potential for regenerative medicine and studies of disease and development. Somatic cell reprogramming involves epigenomic reconfiguration, conferring iPSCs with characteristics similar to embryonic stem (ES) cells. However, it remains unknown how complete the reestablishment of ES-cell-like DNA methylation patterns is throughout the genome. Here we report the first whole-genome profiles of DNA methylation at single-base resolution in five human iPSC lines, along with methylomes of ES cells, somatic cells, and differentiated iPSCs and ES cells. iPSCs show significant reprogramming variability, including somatic memory and aberrant reprogramming of DNA methylation. iPSCs share megabase-scale differentially methylated regions proximal to centromeres and telomeres that display incomplete reprogramming of non-CG methylation, and differences in CG methylation and histone modifications. Lastly, differentiation of iPSCs into trophoblast cells revealed that errors in reprogramming CG methylation are transmitted at a high frequency, providing an iPSC reprogramming signature that is maintained after differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289626      PMCID: PMC3100360          DOI: 10.1038/nature09798

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  37 in total

1.  Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency.

Authors:  Bao-Yang Hu; Jason P Weick; Junying Yu; Li-Xiang Ma; Xiao-Qing Zhang; James A Thomson; Su-Chun Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

2.  Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

Authors:  Frank Soldner; Dirk Hockemeyer; Caroline Beard; Qing Gao; George W Bell; Elizabeth G Cook; Gunnar Hargus; Alexandra Blak; Oliver Cooper; Maisam Mitalipova; Ole Isacson; Rudolf Jaenisch
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

3.  Broader implications of defining standards for the pluripotency of iPSCs.

Authors:  George Q Daley; M William Lensch; Rudolf Jaenisch; Alex Meissner; Kathrin Plath; Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2009-03-06       Impact factor: 24.633

Review 4.  Linking DNA methylation and histone modification: patterns and paradigms.

Authors:  Howard Cedar; Yehudit Bergman
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

5.  Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells.

Authors:  Matthew G Guenther; Garrett M Frampton; Frank Soldner; Dirk Hockemeyer; Maya Mitalipova; Rudolf Jaenisch; Richard A Young
Journal:  Cell Stem Cell       Date:  2010-08-06       Impact factor: 24.633

6.  Relationship between nucleosome positioning and DNA methylation.

Authors:  Ramakrishna K Chodavarapu; Suhua Feng; Yana V Bernatavichute; Pao-Yang Chen; Hume Stroud; Yanchun Yu; Jonathan A Hetzel; Frank Kuo; Jin Kim; Shawn J Cokus; David Casero; Maria Bernal; Peter Huijser; Amander T Clark; Ute Krämer; Sabeeha S Merchant; Xiaoyu Zhang; Steven E Jacobsen; Matteo Pellegrini
Journal:  Nature       Date:  2010-05-30       Impact factor: 49.962

7.  Variation in the safety of induced pluripotent stem cell lines.

Authors:  Kyoko Miura; Yohei Okada; Takashi Aoi; Aki Okada; Kazutoshi Takahashi; Keisuke Okita; Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Mari Ohnuki; Daisuke Ogawa; Eiji Ikeda; Hideyuki Okano; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2009-07-09       Impact factor: 54.908

8.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures.

Authors:  Mark H Chin; Mike J Mason; Wei Xie; Stefano Volinia; Mike Singer; Cory Peterson; Gayane Ambartsumyan; Otaren Aimiuwu; Laura Richter; Jin Zhang; Ivan Khvorostov; Vanessa Ott; Michael Grunstein; Neta Lavon; Nissim Benvenisty; Carlo M Croce; Amander T Clark; Tim Baxter; April D Pyle; Mike A Teitell; Matteo Pelegrini; Kathrin Plath; William E Lowry
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

9.  Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming.

Authors:  Jie Deng; Robert Shoemaker; Bin Xie; Athurva Gore; Emily M LeProust; Jessica Antosiewicz-Bourget; Dieter Egli; Nimet Maherali; In-Hyun Park; Junying Yu; George Q Daley; Kevin Eggan; Konrad Hochedlinger; James Thomson; Wei Wang; Yuan Gao; Kun Zhang
Journal:  Nat Biotechnol       Date:  2009-03-29       Impact factor: 54.908

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  737 in total

Review 1.  Cellular reprogramming: recent advances in modeling neurological diseases.

Authors:  Guo-Li Ming; Oliver Brüstle; Alysson Muotri; Lorenz Studer; Marius Wernig; Kimberly M Christian
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 2.  Somatic Cell Nuclear Transfer Reprogramming: Mechanisms and Applications.

Authors:  Shogo Matoba; Yi Zhang
Journal:  Cell Stem Cell       Date:  2018-07-19       Impact factor: 24.633

3.  Linking inter-individual variability to endocrine disruptors: insights for epigenetic inheritance.

Authors:  Sarah E Latchney; Ashley M Fields; Martha Susiarjo
Journal:  Mamm Genome       Date:  2017-12-07       Impact factor: 2.957

Review 4.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

5.  Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles.

Authors:  Kaifeng Shao; Carmen Koch; Manoj K Gupta; Qiong Lin; Michael Lenz; Stephanie Laufs; Bernd Denecke; Manfred Schmidt; Matthias Linke; Hans C Hennies; Jürgen Hescheler; Martin Zenke; Ulrich Zechner; Tomo Šarić; Wolfgang Wagner
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

6.  How has the study of the human placenta aided our understanding of partially methylated genes?

Authors:  Diane I Schroeder; Janine M LaSalle
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

7.  Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality.

Authors:  Ludovic Zimmerlin; Tea Soon Park; Jeffrey S Huo; Karan Verma; Sarshan R Pather; C Conover Talbot; Jasmin Agarwal; Diana Steppan; Yang W Zhang; Michael Considine; Hong Guo; Xiufeng Zhong; Christian Gutierrez; Leslie Cope; M Valeria Canto-Soler; Alan D Friedman; Stephen B Baylin; Elias T Zambidis
Journal:  Development       Date:  2016-09-22       Impact factor: 6.868

8.  Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells.

Authors:  Mitsutoshi Yamada; Bjarki Johannesson; Ido Sagi; Lisa Cole Burnett; Daniel H Kort; Robert W Prosser; Daniel Paull; Michael W Nestor; Matthew Freeby; Ellen Greenberg; Robin S Goland; Rudolph L Leibel; Susan L Solomon; Nissim Benvenisty; Mark V Sauer; Dieter Egli
Journal:  Nature       Date:  2014-04-28       Impact factor: 49.962

9.  Epigenetic abnormalities in cancer find a "home on the range".

Authors:  Hariharan Easwaran; Stephen B Baylin
Journal:  Cancer Cell       Date:  2013-01-14       Impact factor: 31.743

Review 10.  Epigenetics and chromatin dynamics: a review and a paradigm for functional disorders.

Authors:  T Ordog; S A Syed; Y Hayashi; D T Asuzu
Journal:  Neurogastroenterol Motil       Date:  2012-10-24       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.